- 1Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
- 2Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany
- 3Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
- 4Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 5Institute of Molecular Immunology, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
- 6Bioinformatics and Omics Data Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 7Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
- 8School of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea
- 9Heidelberg University, Medical Faculty, Department of Pediatric Oncology, Hematology, Immunology and Pneumology, Heidelberg, Germany
- 10Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
- 11German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany
- 12Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany
- 13German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany
A Correction on
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
By Li T-F, Rothhaar P, Lang A, Grünvogel O, Colasanti O, Ugarte SMO, Traut J, Piras A, Acosta-Rivero N, Gonçalves Magalhães V, Springer E, Betz A, Huang H-E, Park J, Qiu R, Gnouamozi GE, Mehnert A-K, Thi VLD, Urban S, Muckenthaler M, Schlesner M, Wohlleber D, Binder M, Bartenschlager R, Pichlmair A and Lohmann V (2025) Front. Immunol. 16:1568056. doi: 10.3389/fimmu.2025.1568056
Affiliations “Faculty of Biosciences, Heidelberg University, Heidelberg, Germany” and “School of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea” were omitted from the paper. These affiliations have now been added for author Jeonbin Park.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: RBM39, IRF3, STAT1, STAT2, IFNs, splicing
Citation: Li T-F, Rothhaar P, Lang A, Grünvogel O, Colasanti O, Ugarte SMO, Traut J, Piras A, Acosta-Rivero N, Gonçalves Magalhães V, Springer E, Betz A, Huang H-E, Park J, Qiu R, Gnouamozi GE, Mehnert A-K, Dao Thi VL, Urban S, Muckenthaler M, Schlesner M, Wohlleber D, Binder M, Bartenschlager R, Pichlmair A and Lohmann V (2026) Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response. Front. Immunol. 17:1782019. doi: 10.3389/fimmu.2026.1782019
Received: 06 January 2026; Accepted: 07 January 2026;
Published: 26 January 2026.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2026 Li, Rothhaar, Lang, Grünvogel, Colasanti, Ugarte, Traut, Piras, Acosta-Rivero, Gonçalves Magalhães, Springer, Betz, Huang, Park, Qiu, Gnouamozi, Mehnert, Dao Thi, Urban, Muckenthaler, Schlesner, Wohlleber, Binder, Bartenschlager, Pichlmair and Lohmann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Volker Lohmann, Vm9sa2VyLkxvaG1hbm5AbWVkLnVuaS1oZWlkZWxiZXJnLmRl
Paul Rothhaar1